Cargando…
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
Intestinal fibrosis is an important complication of inflammatory bowel disease (IBD). In the course of the development of fibrosis, certain parts of the intestine become narrowed, significantly destroying the structure and function of the intestine and affecting the quality of life of patients. Chro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971815/ https://www.ncbi.nlm.nih.gov/pubmed/35370998 http://dx.doi.org/10.3389/fimmu.2022.835005 |
_version_ | 1784679716506042368 |
---|---|
author | Wang, Yifei Huang, Bin Jin, Tao Ocansey, Dickson Kofi Wiredu Jiang, Jiajia Mao, Fei |
author_facet | Wang, Yifei Huang, Bin Jin, Tao Ocansey, Dickson Kofi Wiredu Jiang, Jiajia Mao, Fei |
author_sort | Wang, Yifei |
collection | PubMed |
description | Intestinal fibrosis is an important complication of inflammatory bowel disease (IBD). In the course of the development of fibrosis, certain parts of the intestine become narrowed, significantly destroying the structure and function of the intestine and affecting the quality of life of patients. Chronic inflammation is an important initiating factor of fibrosis. Unfortunately, the existing anti-inflammatory drugs cannot effectively prevent and alleviate fibrosis, and there is no effective anti-fibrotic drug, which makes surgical treatment the mainstream treatment for intestinal fibrosis and stenosis. Mesenchymal stem cells (MSCs) are capable of tissue regeneration and repair through their self-differentiation, secretion of cytokines, and secretion of extracellular vesicles. MSCs have been shown to play an important therapeutic role in the fibrosis of many organs. However, the role of MSC in intestinal fibrosis largely remained unexplored. This review summarizes the mechanism of intestinal fibrosis, including the role of immune cells, TGF-β, and the gut microbiome and metabolites. Available treatment options for fibrosis, particularly, MSCs are also discussed. |
format | Online Article Text |
id | pubmed-8971815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89718152022-04-02 Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy Wang, Yifei Huang, Bin Jin, Tao Ocansey, Dickson Kofi Wiredu Jiang, Jiajia Mao, Fei Front Immunol Immunology Intestinal fibrosis is an important complication of inflammatory bowel disease (IBD). In the course of the development of fibrosis, certain parts of the intestine become narrowed, significantly destroying the structure and function of the intestine and affecting the quality of life of patients. Chronic inflammation is an important initiating factor of fibrosis. Unfortunately, the existing anti-inflammatory drugs cannot effectively prevent and alleviate fibrosis, and there is no effective anti-fibrotic drug, which makes surgical treatment the mainstream treatment for intestinal fibrosis and stenosis. Mesenchymal stem cells (MSCs) are capable of tissue regeneration and repair through their self-differentiation, secretion of cytokines, and secretion of extracellular vesicles. MSCs have been shown to play an important therapeutic role in the fibrosis of many organs. However, the role of MSC in intestinal fibrosis largely remained unexplored. This review summarizes the mechanism of intestinal fibrosis, including the role of immune cells, TGF-β, and the gut microbiome and metabolites. Available treatment options for fibrosis, particularly, MSCs are also discussed. Frontiers Media S.A. 2022-03-18 /pmc/articles/PMC8971815/ /pubmed/35370998 http://dx.doi.org/10.3389/fimmu.2022.835005 Text en Copyright © 2022 Wang, Huang, Jin, Ocansey, Jiang and Mao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Wang, Yifei Huang, Bin Jin, Tao Ocansey, Dickson Kofi Wiredu Jiang, Jiajia Mao, Fei Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title | Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title_full | Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title_fullStr | Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title_full_unstemmed | Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title_short | Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy |
title_sort | intestinal fibrosis in inflammatory bowel disease and the prospects of mesenchymal stem cell therapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971815/ https://www.ncbi.nlm.nih.gov/pubmed/35370998 http://dx.doi.org/10.3389/fimmu.2022.835005 |
work_keys_str_mv | AT wangyifei intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy AT huangbin intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy AT jintao intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy AT ocanseydicksonkofiwiredu intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy AT jiangjiajia intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy AT maofei intestinalfibrosisininflammatoryboweldiseaseandtheprospectsofmesenchymalstemcelltherapy |